Ohio Board Of Pharmacy Files Amended Program Rules With The Common Sense Initiative Office

OPPORTUNITY FOR PUBLIC COMMENT:
STATE BOARD OF PHARMACY FILES AMENDED PROGRAM RULES WITH THE COMMON SENSE INITIATIVE OFFICE – MARCH 22, 2021

OHIO:  The State of Ohio Board of Pharmacy has filed amended program rules with the Common Sense Initiative Office (CSI). Those impacted by the proposed rules may submit comments to CSI and the Board for review until close of business on April 2, 2021.

The CSI Business Impact Analysis, the amended rule text, and instructions on how to provide comments are available on the Board of Pharmacy’s proposed rules page (under the Common Sense Initiative header): www.pharmacy.ohio.gov/proposed.

Ohio Medical Marijuana Control Program Mandatory Product Recall – 3/16/21

OHIO:  The Ohio Medical Marijuana Control Program (MMCP) is issuing a mandatory product recall on plant material sold to dispensaries by processor, GTI Ohio, LLC. This recall is being initiated by the MMCP because the product did not receive the full battery of required testing prior to being sold at dispensaries. The recalled products were not tested for heavy metals and mycotoxins. The MMCP is investigating this matter and will issue an executive summary at the conclusion of the investigation.

AFFECTED PRODUCTS:
Product Name:
  • “& Shine” Select Grind Lightly Ground Trim – Strain Name Koala Mints
  • “& Shine” Select Grind Lightly Ground Trim – Strain Name Blueberry Cheesecake
  • “& Shine” Select Grind Lightly Ground Trim – Strain Name Wedding Cake
Purchase Dates: February 15, 2021 – Present
Products Purchased from: RISE Dispensary (Cleveland), RISE Dispensary (Lakewood), RISE Dispensary (Lorain), and RISE Dispensary (Toledo)
Processor Name: GTI Ohio LLC
Product ID:
  • M00000144218: Tier 1 Vap-Hybrid-13.6-0-14.15
  • M00000145710: Tier 1 Vap-Hybrid-21.1-0-14.15
  • M00000145715: Tier 1 Vap-Hybrid-14.5-0-14.15
  • M00000146514: Tier 1 Vap-Hybrid-21.6-0-14.15
No reports of adverse reactions for this product have been reported to the MMCP at this time.
Patients who have purchased the recalled product should stop using it. All unused product should be returned to the dispensary where purchased. Returned products will not count toward a patient’s 90-day possession limit. For more information on returns, please contact the dispensary where the product was purchased.
Anyone who thinks that they may be experiencing serious or life-threatening issues should seek immediate medical attention. Patients are reminded that any adverse reactions should be reported to the MMCP toll-free helpline (1-833-464-6627).

Ohio Medical Marijuana Advisory Committee March 2021 Meeting Notice

Update from the Ohio Medical Marijuana Control Program

 

MEETING NOTICE MEDICAL MARIJUANA ADVISORY COMMITTEE

March 25, 2021

10:00 a.m.

OHIO: The Advisory Committee meeting will be held virtually via Microsoft Teams.  Instructions to access the Teams Meeting will be posted here the morning of March 25, and via email update.
To register for email updates please visit our website.
NOTE: The Advisory Committee will not be accepting testimony or public comments at this meeting. Public comment can be submitted at: www.medicalmarijuana.ohio.gov/contactus.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For October 2020

OHIO:   The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for October 2020. These numbers include:

  • 192,777 Recommendations
  • 147,678 Registered patients
    • 10,175 Patients with Veteran Status
    • 10,781 Patients with Indigent Status
    • 799 Patients with a Terminal Diagnosis
  • 123,485 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 16,691 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Ohio Medical Marijuana Advisory Committee November 2020 Virtual Meeting Link

 

OHIO: The Medical Marijuana Advisory Committee will hold a meeting virtually via Skype at 10:00 AM. Click here for a link to access the virtual meeting.

To join by phone, call 614-721-2972 and use access code 931714645.

 

Ohio Medical Marijuana Advisory Committee November 2020 Meeting Agenda

 

OHIO: The Medical Marijuana Advisory Committee will hold a meeting virtually via Skype on November 12, 2020.

AGENDA MEDICAL MARIJUANA ADVISORY COMMITTEE MEETING

November 12, 2020 10:00 a.m.

The Advisory Committee meeting will be held virtually via Skype.

Instructions to access the Skype Meeting will be posted here the morning of November 12, and via email update.

NOTE: The Advisory Committee will not be accepting testimony or public comments at this meeting.

10:00 a.m.

ROLL CALL AND MINUTES REVIEW

▪ Advisory Committee Members

10:05 a.m.

MEDICAL MARIJUANA CONTROL PROGRAM UPDATE

▪ Patient and Caregiver Update (Maerten-Moore)

▪ Dispensary Update (Maerten-Moore)

▪ Program Update (Maerten-Moore)

▪ Patient Survey Results (Maerten-Moore)

▪ Commerce Licensee Updates (McIlvaine)

▪ Program Sales and Product Data (McIlvaine)

▪ Commerce Initiatives (McIlvaine)

▪ Petitions for Qualifying Conditions (Pollock) o Current petition period and criteria o 2021 petition period dates

▪ Physicians with a CTR (Pollock)

▪ COVID-19 Update (Pollock)

Ohio Board Of Pharmacy Publishes Updated MMJ Patient & Caregiver Numbers For September 2020

OHIO:  The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for July 2020. These numbers include:

  • 181,566 Recommendations
  • 140,409 Registered patients
    • 9,756 Patients with Veteran Status
    • 10,290 Patients with Indigent Status
    • 765 Patients with a Terminal Diagnosis
  • 115,155 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 15,854 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.

Ohio Board Of Pharmacy Publishes Updated Patient & Caregiver Numbers For June 2020

OHIO: The State of Ohio Board of Pharmacy today published updated patient & caregiver numbers for June 2020. These numbers include:

  • 147,245 Recommendations
  • 116,497 Registered patients
    • 8,349 Patients with Veteran Status
    • 8,713 Patients with Indigent Status
    • 644 Patients with a Terminal Diagnosis
  • 91,330 Unique patients who purchased medical marijuana (as reported to OARRS by licensed dispensaries)
  • 13,140 Registered Caregivers

For the full list of program numbers, please visit the Program Update page.